SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SMSPHARMA and BSE: 532815 (ISIN INE812G01025).
It has a market capitalisation of ₹4,071 crore, a last close of ₹434.65 on 2026-10-19, a one-year return of 48.3%.
Valuation: a price-to-earnings ratio of 39.64x, a price-to-book ratio of 5.18x, a dividend yield of 0.1%.
Profitability: return on equity of 14.3%, return on capital employed of 15.2%, an operating margin of 19.3%.
Growth: sales growth of 19.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.46x, promoter holding of 68.1%.
| Metric | Value |
|---|---|
| Market capitalisation | 4,071 |
| Last close | ₹434.65 |
| P/E (TTM) | 39.64x |
| P/B | 5.18x |
| Dividend yield | 0.1% |
| ROE (FY) | 14.3% |
| ROCE (FY) | 15.2% |
| Operating margin (TTM) | 19.3% |
| Sales growth, 3-year CAGR | 19.3% |
| Debt / equity | 0.46x |
| Promoter holding | 68.1% |
| 1-year return | 48.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means